Patent US-7479538: Enzolytics has a License Agreement for US Patent 7479538. The claim is Irreversibly-inactivated Pepsinogen Fragments for Modulating Immune Function.
stervc ‘ol pal.... nice to see you. World just finding out about this gem.... a solid, extended run coming imo.... through getting current and full Merger. A LOT working here. I’m keeping a bunch of this one...$$ Coming imo.
...glad your here stervc: classiest man on iHub ive always thought.....When you put up with some of my gruff this year so thanks… I’m sorry…pretty cool to have to HIV-1 killing biotechs team up, w applications for other viruses too. Read BG Europe’s description of their 80% patient HIV kill rate...then about the no side effects and how ImmunH is also an immune system booster against viruses.
All this and already passed Phase III: 1 in 5,000 drugs make it to Phase IV like enzc.
Anyways got to go days like this I don’t wanna work. ha